15–21 Jun 2025
Yerevan
Asia/Yerevan timezone

Optimization of Calibration Factors and Recovery Coefficients for Lu-177 SPECT/CT Using Phantoms

17 Jun 2025, 17:11
1m
IAPP NAS RA - Yerevan

IAPP NAS RA - Yerevan

Speaker

Mohammed Alkhorayef (King Saud University)

Description

Accurate quantification of Lu-177 uptake in radionuclide therapy requires precise calibration of SPECT/CT systems. This study aimed to determine calibration factors (CF) and recovery coefficients (RC) using Jaszczak and NEMA Image Quality phantoms under standardized acquisition and reconstruction protocols. Lu-177 SPECT/CT was performed with a dual-energy window protocol: main photopeak (208 keV ± 10%) and scatter correction windows (±5%). The Jaszczak phantom provided CF values, while the NEMA Image Quality phantom assessed RC across varying sphere-to-background concentration ratios. SPECT acquisition employed MELP collimators with 60 projections (10s/projection, 128x128 matrix, and zoom 1.0). Reconstruction utilized hybrid recon (5i, 16ss) with resolution recovery, scatter correction, and attenuation correction. The CF derived from the Jaszczak phantom was [10.6: 10.8 CPS/MBq]. RC varied significantly with sphere size, highlighting the dependence of quantification accuracy on spatial resolution. Scatter correction and resolution recovery were critical for improving RC for smaller spheres (<10 mm). This study establishes robust calibration and recovery protocols for Lu-177 SPECT/CT imaging, facilitating enhanced accuracy in dosimetry calculations. The use of optimized energy windows and advanced reconstruction algorithms significantly impacts quantification reliability. These findings strongly advocate for the standardization of Lu-177 imaging protocols, underscoring their crucial role in clinical applications.

Authors

Abdelmoneim Sulieman (King Saud bin Abdulaziz University for Health Sciences) David Bradley (University of Surrey and Sunway University) Dr Meshari Alnaaimi (Kuwait Cancer Control Center) Mohammed Alkhorayef (King Saud University) Dr Musa Alduaij (Kuwait Cancer Control Center)

Presentation materials